SecBot SecBot

IBO

IMPACT BIOMEDICAL INC.
NYSE· Pharmaceutical Preparations· Inc. NV· CIK 0001834105 Biotech & Drug Discovery
$3.73 +0.13 (+3.61%)
Oct 26 4:00 PM ET · prev $3.60
Market cap
$32.5M
Nano cap
Next earnings
Nov 6
in 11 days
1 year
−49.5%
from $7.38 · Oct 27
30 days
−33.5%
from $5.61
52-week range
$2.68–9.87
−62% from high · low Oct 16
Avg volume 20D
14.9K
Oct 19 spike 47.9K
Short interest
30.2K
≈0.3% of shares · −94.3%
Days to cover
2.0
at average volume
Insider net
−$59.5K
0 buyers · 3 sellers · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
2
analyzed by SecBot
SecBot read BEARISH 3 reports · latest
Balance 3 bearish · 0 bullish oldest → newest, height = score
Avg score ·High conf. 2/3 ·Next Earnings date, Nov 6, 2026
Strongest BEARISH DSS, Inc., a major stockholder, filed Form 144 to sell 31,939,778 shares of Impact Biomedical Inc., valued…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBEARISH

    3 insiders sold $59.5K.

  • InstitutionsMIXED

    Q2 2026: 0 added (0 new), 2 trimmed or exited.

  • Short sellersCOVERING

    Short interest −94.3% to 30.2K shares. 2.0 days to cover, ≈0.3% of shares.

  • TrendDOWNTREND

    30% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
CITIGROUP INCNEAR_EXIT1—
UBS Group AGNEAR_EXIT2,400$1.1K
GEODE CAPITAL MANAGEMENT, LLCDOUBLED1,192,925$716.2K
STATE STREET CORPDOUBLED607,897$364.7K
NORTHERN TRUST CORPDOUBLED243,943$146.4K
UBS Group AGDOUBLED32,417$19.4K
CITIGROUP INCDOUBLED353$212.00
VANGUARD GROUP INCDOUBLED814,885$411.5K

Quarterly 13F filings are due 45 days after each quarter ends.

Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 6, 2026
Earnings date
IBO Q3 2026 Earnings Scheduled — 2026-11-06
Recent
Oct 21, 2026
Trading halt
Halt Resumed: IBO — trading resumed after M (Volatility Trading Pause)
Halted 2026-10-21T17:27:18.000Z | Resumed 2026-10-21T17:32:18.000Z
Oct 21, 2026
Trading halt
Trading Halt: IBO — M (Volatility Trading Pause)
Impact BioMedical, Inc. Common Stock | Market: AMEX | Code: M — Volatility Trading Pause
Oct 20, 2026
Trading halt
Halt Resumed: IBO — trading resumed after M (Volatility Trading Pause)
Halted 2026-10-20T17:36:00.000Z | Resumed 2026-10-20T17:46:00.000Z
Oct 20, 2026
Trading halt
Trading Halt: IBO — M (Volatility Trading Pause)
Impact BioMedical, Inc. Common Stock | Market: AMEX | Code: M — Volatility Trading Pause
Oct 19, 2026
Trading halt
Halt Resumed: IBO — trading resumed after M (Volatility Trading Pause)
Halted 2026-10-19T14:18:00.000Z | Resumed 2026-10-19T14:23:00.000Z

Insider ledger

Form 4
$0
bought · 0 insiders
$59.5K
sold · 3 insiders
DateInsiderTypeValue
Sep 24, 2026
DSS, INC.
10%+ Owner
SELL$1.1K
Sep 23, 2026
DSS, INC.
10%+ Owner
SELL$187.65
Sep 22, 2026
DSS, INC.
10%+ Owner
SELL$397.65
Mar 27, 2026
Macko Todd D
Chief Financial Officer
SELL$24.4K
Mar 25, 2026
Macko Todd D
Chief Financial Officer
SELL$961.28
Mar 23, 2026
Grady Jason
Director
SELL$32.5K

Earnings setup

Estimates
Nov 6
reports in 11 days
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Sep 30, 2026
30,169
shares short
-94.3%
vs prior settlement
2.0
days to cover
≈0.3%
of shares outstanding
Trading halts
Oct 21, 2026Volatility PauseResumed
Oct 20, 2026Volatility PauseResumed
Oct 19, 2026Volatility PauseResumed
Oct 16, 2026Volatility PauseResumed
Oct 15, 2026Volatility PauseResumed
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 21, 2026 Trading halt
Halt Resumed: IBO — trading resumed after M (Volatility Trading Pause)
Halted 2026-10-21T17:27:18.000Z | Resumed 2026-10-21T17:32:18.000Z
Sep 24, 2026 Insider
DSS, INC. sold 156 shares
10%+ Owner @ $7.06 ($1.1K)
Sep 23, 2026 Insider
DSS, INC. sold 27 shares
10%+ Owner @ $6.95 ($187.65)
Sep 22, 2026 Insider
DSS, INC. sold 723 shares
10%+ Owner @ $0.5500 ($397.65)
Jun 30, 2026 Inst.
CITIGROUP INC — NEAR_EXIT
1 shares (—)
Jun 30, 2026 Inst.
UBS Group AG — NEAR_EXIT
2,400 shares ($1.1K)
Apr 29, 2026 SEC
DSS, Inc., a major stockholder, filed Form 144 to sell 31,939,778 shares of Impact Biomedical Inc., valued at…
144 — Impact 8/10
Apr 3, 2026 Press
Impact BioMedical (IBO) disclosed that its 2025 audit opinion includes a 'going concern' qualification, signaling…
Impact 8/10

SecBot reports

2 filings · 1 press release · 0 bullish · 2 bearish
All IBO filing & press-release reports (3)